TLM Utility Nav

HCV Elimination: Past, Present and Future, 2013, 2024 and 2030

Description

10 years after HCV treatment 2nd Gen DAAs broke the warehouse, where are we now? What have we learned? and can we actually End Hep C by 2030? HCV elimination: different approaches to elimination around the country, past, present and future.

Presentations

2:00 PM - 2:15 PM
Nov 15 2024
San Diego, CA

Ten Years since DAAs: Achievements and Opportunities

Mark Sulkowski, MD, FAASLD, Presenter
Hepatitis
Liver Cancer
Patient Program
2:15 PM - 2:30 PM
Nov 15 2024
San Diego, CA

Moving the Needle: Harm Reduction Best Practices in HCV Elimination

Clayton AA Ruley, MSS, MLSP, LSW, Presenter
Hepatitis
Liver Cancer
Patient Program
2:30 PM - 2:45 PM
Nov 15 2024
San Diego, CA

Local HCV Elimination Efforts: End Hep C SD

Richard Jaenisch, MPH, Presenter
Hepatitis
Liver Cancer
Patient Program
2:45 PM - 3:05 PM
Nov 15 2024
San Diego, CA

Abstracts Tour

Jennifer Price, MD, PhD, Presenter
Hepatitis
Liver Cancer
Patient Program
3:05 PM - 3:20 PM
Nov 15 2024
San Diego, CA

Panel Discussion

George N. Ioannou, MD, FAASLD, Moderator
Hepatitis
Liver Cancer
Patient Program
3:20 PM - 3:30 PM
Nov 15 2024
San Diego, CA

Discussion & Audience Q&A - All Presenters

Richard Jaenisch, MPH, Moderator
Hepatitis
Liver Cancer
Patient Program

Objectives

  • A better understanding of HCV Elimination efforts connected components, History, and populations that require more attention to achieve elimination: incarcerated people, PWUD, (and AI/AN or International Success)
  • A key takeaway from this session should be to spur interest in helping patients with HCV see themselves as part of a global effort working together, not only are their lives improved, but the world for it. With stigma as strong as it is, a message of hope is only as strong as the messenger, a message of hope and belonging is stronger and helps at eroding stigma via self-esteem and a perception of a stronger "invisible" support network.